Tillkännagivande • May 11
Altor Fund V (No. 2) AB, managed by Altor Equity Partners AB proposed to acquire Sleep Cycle AB (publ) (OM:SLEEP) for approximately SEK 500 million. Altor Fund V (No. 2) AB, managed by Altor Equity Partners AB proposed to acquire Sleep Cycle AB (publ) (OM:SLEEP) for approximately SEK 500 million on May 11, 2026. A cash consideration valued at SEK 24.5 per share will be paid by Altor Fund V (No. 2) AB, managed by Altor Equity Partners AB. As part of the acquisition, Maciej Drejak has not participated and will not participate in the Board’s handling of or decisions related to the Offer due to conflict of interest.
The Board is evaluating the Offer and will announce its opinion regarding the Offer no later than two weeks before the end of the acceptance period, which is expected to commence around May 28, 2026 and expire around June 22, 2026, subject to any extensions.
Skandinaviska Enskilda Banken AB acted as financial advisor for Sleep Cycle AB. Mannheimer Swartling Advokatbyrå Aktiebolag acted as legal advisor for Sleep Cycle AB. DNB Carnegie Investment Bank AB acted as financial advisor for Altor Equity Partners AB. Tillkännagivande • Apr 28
Sleep Cycle AB (publ) to Report Q1, 2026 Results on Apr 29, 2026 Sleep Cycle AB (publ) announced that they will report Q1, 2026 results at 7:30 AM, Central European Standard Time on Apr 29, 2026 Tillkännagivande • Mar 10
Sleep Cycle AB (publ) Announces Hans Skruvfors Declines Re-Election to its Board of Directors, Effective 13 April 2026 Sleep Cycle AB (publ) at its Annual General Meeting to be held on 13 April 2026, announced Hans Skruvfors has declined re-election to the Board of Directors for the AGM 2026. Tillkännagivande • Jan 21
Sleep Cycle AB (publ) to Report Fiscal Year 2025 Results on Feb 04, 2026 Sleep Cycle AB (publ) announced that they will report fiscal year 2025 results at 7:30 AM, Central European Standard Time on Feb 04, 2026 Tillkännagivande • Oct 28
Sleep Cycle AB (Publ) Elects Christian Kanstrup as Member of the Board of Directors At the Extraordinary General Meeting of Sleep Cycle AB (publ) on 28 October 2025, it was resolved to elect Christian Kanstrup as new member of the Board of Directors. The EGM resolved, in accordance with the Nomination Committee’s proposal, to increase the Board of Directors with one member through new election of Christian Kanstrup as Board member for the period until the end of the next Annual General Meeting. The EGM further resolved that the annual fees per Board member, as resolved by the Annual General Meeting, shall continue to apply. Fees are to be paid to the incoming Board member pro rata in relation to the Board member’s actual duty period. Tillkännagivande • Jun 03
Sleep Cycle Launches Clinical Study for AI-Powered Sleep Apnea Sleep Cycle announced the start of a clinical study to validate its upcoming smartphone-based feature for screening and monitoring obstructive sleep apnea (OSA) with no additional hardware or wearables required. This milestone underscores the company's commitment to pioneering accessible, technology-driven health solutions that empower users to better understand and manage their sleep, unlocking a new era of sleep health. Obstructive sleep apnea affects an estimated 950 million adults aged 30-69 worldwide, with nearly 80% of cases remaining undiagnosed. This silent epidemic contributes to numerous health complications, including cardiovascular disease, cognitive decline, and reduced quality of life. The global home testing market for sleep apnea is projected to grow from USD 712 million in 2025 to USD 966 million by 2035, highlighting the urgent demand for scalable, cost-efficient, and accessible solutions. By leveraging widely available smartphone technology and its proprietary algorithms, Sleep Cycle's upcoming sleep apnea feature aims to help users bridge this gap. With an intuitive interface and competitive pricing, the new solution is designed to democratize sleep health and improve early detection, particularly in underserved populations who may not have access to specialized sleep clinics or expensive testing equipment. The clinical study is led by Dr. Mike Gradisar, Head of Sleep Science at Sleep Cycle, as Principal Investigator of the study, along with Dr. Mikael Kageback, Chief Technology Officer and PhD in AI and Machine Learning. Together, they bring deep expertise in behavioral sleep medicine and applied AI, reinforcing Sleep Cycle's evidence-based approach to innovation. Tillkännagivande • Dec 04
Sleep Cycle Announces the Rollout of Sleep Stages Sleep Cycle announced the rollout of Sleep Stages, a groundbreaking new technology that allows users to measure their sleep stages and how long they spend in the dream stage each night. This technology is the first to combine breathing patterns and movement sounds, with only a smartphone, to accurately identify sleep stages such as REM sleep (the phase where most dreaming occurs), light sleep, and deep sleep, offering users a deeper understanding of their sleep patterns. The technology is based on AI and machine learning trained on an extensive dataset of polysomnographic data collected in a sleep lab, in addition to the data Sleep Cycle has gathered since its inception in 2009. It will be rolled out in stages to all iOS users in the initial phase but will later become part of Sleep Cycle's premium features on iOS. Mikael Kågebäck, Chief Technology Officer at Sleep Cycle and Ph.D. in Machine Learning, describes the new technology as a significant breakthrough in sleep analysis, where traditional methods still rely on tools that require physical contact. The Sleep Stages feature and technology is a significant milestone for Sleep Cycle and the broader field of sleep technology. Sleep is fundamental to feeling your best every day, and this feature is designed for individuals constantly looking for ways to improve their wellbeing through sleep. Available exclusively on iOS, Sleep Stages enhances Sleep Cycle's reputation as a leader in non-contact sleep analysis. Tillkännagivande • Oct 07
Sleep Cycle AB (Publ) Appoints Nominating Committee The nominating committee for Sleep Cycle AB's Annual General Meeting 2025, has been appointed by the company's three largest shareholders, or shareholder groups, with each selecting a representative to the nominating committee. According to the instructions for the nominating committee at Sleep Cycle that were resolved at the Annual General Meeting on 11 april 2024, the nominating committee shall, in addition to the Chairman of the Board, consist of representatives from the three largest shareholders registered as per August 31 of the year that falls before the Annual General Meeting. Following the confirmation of the nominating committee, the Chairman of the Board has summoned the nominating committee for its first meeting. The nominating committee consists of the following representatives: Martin Anthonsen, appointed by MCGA AB and H265 AB, who respectively represent 21.5% of the votes and together represent 42.9% of the votes. Erik Olsson, appointed by GLA Invest SA, representing 23.6% of the votes. Erik Bertilsson, appointed by Lancelot Asset Management AB, representing 2.9% of the votes. Anne Broeng, Chairman of the Board of Sleep Cycle. The nominating committee combined represent 69.4% of the votes in the company. The committee has appointed Martin Anthonsen as chairman. Tillkännagivande • Sep 23
Sleep Cycle AB (publ) to Report Fiscal Year 2024 Results on Feb 04, 2025 Sleep Cycle AB (publ) announced that they will report fiscal year 2024 results on Feb 04, 2025 Tillkännagivande • Mar 12
Sleep Cycle AB (Publ) Announces Non-Reelection of Board of Directors Sleep Cycle AB (publ) announced After more than three years of service on the board, Olof Nilsson and Rasmus Järborg have informed the nomination committee that they will not stand for re-election. Tillkännagivande • Feb 27
Sleep Cycle AB (Publ) Announces Executive Changes Sleep Cycle AB (publ) announced changes to the senior management team. Peter Alsterberg will join Sleep Cycle as Chief Commercial Officer (CCO), a newly established position. Additionally, Chief Product Officer, Samuel Cyprian, and Chief HR Officer, Cecilia Mikkov, have declined to move to Gothenburg HQ and have decided to leave Sleep Cycle. Samuel Cyprian and Cecilia Mikkov have declined to relocate to the Gothenburg HQ and will therefore step down from Sleep Cycle on April 30, 2024. They will both remain in external advisory roles until August 1, 2024. The process of hiring successors will begin immediately. Peter Alsterberg has 20 years of experience from management and strategy consulting across a range of industries and global markets. He most recently served as Executive Vice President, Sweden, Denmark & Finland at Frog (part of Capgemini Invent). Other positions have included Vice President at Capgemini Invent and Business advisor and Project manager at Nordea. As Chief Commercial Officer at Sleep Cycle, Peter will focus on partnerships, revenue management and new revenue streams by leveraging Sleep Cycle’s data and platform. Peter Alsterberg will join Sleep Cycle no later than second quarter 2024. Tillkännagivande • Jan 23
Sleep Cycle AB (publ) Announces Strategic Move to Unify Team in Gothenburg Sleep Cycle AB (publ) announced a strategic move to enhance teamwork and boost operational efficiency. The company intends to consolidate its workforce at the Gothenburg headquarters, which would mark a decisive shift in its operational structure and position the organization to meet current challenges and eye future growth. In First Quarter 2024, Sleep Cycle is launching initiatives aimed at improving operational efficiency and unifying the team around a new strategy, which will be launched in Q2. The biggest organizational change entails phasing out the Stockholm office. All Stockholm-based employees, including remote workers, will be offered the same jobs at the Gothenburg HQ. These employees will receive relocation reimbursement packages. The move is not part of an articulated cost-cutting program, although consolidating Sleep Cycle's two offices enables the company to bring all functions closer together, creating a more efficient organization and saving money. Tillkännagivande • Nov 11
Sleep Cycle AB Appoints Nominating Committee The nominating committee for Sleep Cycle AB’s Annual General Meeting 2024, has been appointed by the company's three largest shareholders, or shareholder groups, with each selecting a representative to the nominating committee. According to the instructions for the nominating committee at Sleep Cycle that were resolved at the Annual General Meeting on 19 May 2021, the nominating committee shall, in addition to the Chairman of the Board, consist of representatives from the three largest shareholders registered as per September 30 of the year that falls before the Annual General Meeting. Following the confirmation of the nominating committee, the Chairman of the Board has summoned the nominating committee for its first meeting. The nominating committee consists of the following representatives: Martin Anthonsen, appointed by MCGA AB and H265 AB, who respectively represent 21.5% of the votes and together represent 42.9% of the votes. Erik Olsson, appointed by GLA Invest SA, representing 23.6% of the votes. Anna Sundberg, appointed by Handelsbanken Fonder, representing 3.6% of the votes. Anne Broeng, Chairman of the Board of Sleep Cycle. Tillkännagivande • Aug 25
Sleep Cycle AB (Publ) Announces CEO Changes In agreement with the company's board, Carl Johan Hederoth steps down as CEO of Sleep Cycle AB (publ). The board has decided to appoint Erik Jivmark as the new CEO of Sleep Cycle as of 1 November 2023. Erik Jivmark has extensive international experience from leading positions within digital products and services. Erik comes from the role as CEO of Volvo Car Mobility AB and leading the Volvo Cars Stockholm Tech Hub. Before that Erik was the Global Director of Digital at Volvo Cars AB based in both Sweden and the U.S. He has a background from Accenture focusing on digital and commercial transformation. Carl Johan Hederoth will remain in his role as CEO until 30 September 2023 and will continue to be at the disposal of the company during the remaining of his notice period. To secure a seamless handover, the company's CFO Per Andersson will act as interim CEO from 1 October 2023 until Erik Jivmark takes over on 1 November 2023. Tillkännagivande • Feb 10
Sleep Cycle AB (publ) Proposes Extra Ordinary Dividend for 2022 The Board of Directors in Sleep Cycle AB (publ) has a adopted a dividend policy with the goal that dividend shall, over time, amount to between 40% and 60% of annual net profit after taxes. The Board of Directors proposes dividend of SEK 7.00 per share, corresponding to SEK 141.9 million based on outstanding shares per 10 February 2023. SEK 6.00 per share as extra ordinary dividend for 2022. Tillkännagivande • Feb 07
Sleep Cycle AB (publ) to Report Nine Months, 2023 Results on Oct 28, 2023 Sleep Cycle AB (publ) announced that they will report nine months, 2023 results on Oct 28, 2023 Tillkännagivande • Jan 26
Sleep Cycle AB (Publ) Announces Executive Changes Sleep Cycle AB (publ) announced that Samuel Cyprian, Chief Commercial Officer, will take on the role of Chief Product Officer and lead both teams. As a result, Sandra Hansson will leave the management team for another role in Sleep Cycle and the position as Chief Commercial Officer will not be appointed. Tillkännagivande • Jan 16
Sleep Cycle AB (publ) to Report Q4, 2022 Results on Feb 10, 2023 Sleep Cycle AB (publ) announced that they will report Q4, 2022 results on Feb 10, 2023 Tillkännagivande • Dec 21
Velvet Cichlid Intends to Promote A Delisting of the Sleep Cycle Shares from Nasdaq Stockholm Velvet Cichlid AB (the "Bidder"), a company controlled by a consortium consisting of GLA Invest SA, MCGA AB, h265 AB and Petter Wallin (the "Consortium"), announced a cash offer to the shareholders of Sleep Cycle AB (publ) ("Sleep Cycle" or the "Company"), (the "Offer"). Sleep Cycle's shares are admitted to trading on Nasdaq Stockholm, Small Cap. The Bidder offers SEK 42.50 in cash per share in Sleep Cycle (the "Offer Price"). In the event that the Bidder, whether in connection with the Offer or otherwise, becomes the owner of shares representing more than 90% of the shares in Sleep Cycle, the Bidder intends to commence a compulsory acquisition procedure under the Swedish Companies Act to acquire all remaining shares in Sleep Cycle. In connection therewith, the Bidder intends to promote a delisting of the Sleep Cycle shares from Nasdaq Stockholm. Tillkännagivande • Nov 02
Sleep Cycle AB (Publ) Announces Board Appointments The nominating committee for Sleep Cycle AB's Annual General Meeting 2023, has been appointed by the company's three largest shareholders, or shareholder groups, with each selecting a representative to the nominating committee. Following the confirmation of the nominating committee, the Chairman of the Board has summoned the nominating committee for its first meeting. The nominating committee consists of the following representatives: Mathias Høyer, appointed by MCGA AB and H265 AB, who respectively represent 21.05% of the votes and together represent 42.1% of the votes. Erik Olsson, appointed by GLA Invest SA, representing 22.7% of the votes. Anna Sundberg, appointed by Handelsbanken Fonder, representing 7.1% of the votes. Lars Berg, Chairman of the Board of Sleep Cycle. Reported Earnings • Oct 30
Third quarter 2022 earnings released: EPS: kr0.55 (vs kr0.37 in 3Q 2021) Third quarter 2022 results: EPS: kr0.55 (up from kr0.37 in 3Q 2021). Revenue: kr55.1m (up 13% from 3Q 2021). Net income: kr10.7m (up 50% from 3Q 2021). Profit margin: 20% (up from 15% in 3Q 2021). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Software industry in Germany. Tillkännagivande • Oct 28
Sleep Cycle AB (Publ) Announces Lars Berg, Chairman, Declines Re-Election At the 2023 Annual General Meeting The chairman of the board of directors in Sleep Cycle AB, Lars Berg, has informed the nomination committee that he declines re-election at the 2023 annual general meeting. Valuation Update With 7 Day Price Move • Sep 07
Investor sentiment deteriorated over the past week After last week's 20% share price decline to €3.92, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 19x in the Software industry in Germany. Total loss to shareholders of 47% over the past year. Valuation Update With 7 Day Price Move • Aug 23
Investor sentiment improved over the past week After last week's 19% share price gain to €4.64, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 21x in the Software industry in Germany. Total loss to shareholders of 35% over the past year. Reported Earnings • Jul 30
Second quarter 2022 earnings released: EPS: kr0.52 (vs kr0.50 loss in 2Q 2021) Second quarter 2022 results: EPS: kr0.52 (up from kr0.50 loss in 2Q 2021). Revenue: kr52.7m (up 20% from 2Q 2021). Net income: kr10.1m (up kr19.2m from 2Q 2021). Profit margin: 19% (up from net loss in 2Q 2021). Over the next year, revenue is forecast to grow 27%, compared to a 7.7% growth forecast for the industry in Germany. Tillkännagivande • May 14
Sleep Cycle Appoints Mike Gradisar as Head of Sleep Science Sleep Cycle announced the appointment of Professor Mike Gradisar as Sleep Cycle's new Head of Sleep Science. Professor Gradisar has previously been engaged with Sleep Cycle as a sleep expert. With his new position, Professor Gradisar will extend his engagement with Sleep Cycle and become a vital contributor within the product development team. Reported Earnings • Apr 29
First quarter 2022 earnings released: EPS: kr0.52 (vs kr0.25 in 1Q 2021) First quarter 2022 results: EPS: kr0.52 (up from kr0.25 in 1Q 2021). Revenue: kr50.3m (up 20% from 1Q 2021). Net income: kr10.1m (up 172% from 1Q 2021). Profit margin: 20% (up from 8.8% in 1Q 2021). Over the next year, revenue is forecast to grow 24%, compared to a 14% growth forecast for the industry in Germany. Tillkännagivande • Mar 05
Sleep Cycle Launches `Auto Sleep Tracker' for Apple Watch Sleep Cycle announced the launch of `Auto Sleep Tracker' - a highly anticipated feature catering to a growing segment of health and tech-focused Sleep Cycle users, longing for a more seamless Apple Watch integration. The new feature will minimize inconsistencies and gaps in users' sleep data, enabling everyday sleep tracking with minimal disruption. Sleep Cycle's 'Auto Sleep Tracker' automatically draws information from Apple Health gathered via the Apple Watch to provide the user with detailed sleep analysis and automated consistency of personal sleep data. This new functionality is a response to the global trend of increasing wearables usage. It will enable more comprehensive health tracking through a closer integration with the Apple Watch's core functionalities, and allow for even more insightful sleep tracking. Reported Earnings • Feb 16
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: kr0.43 (down from kr2.94 in FY 2020). Revenue: kr183.3m (up 15% from FY 2020). Net income: kr8.11m (down 82% from FY 2020). Profit margin: 4.4% (down from 28% in FY 2020). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 26%, compared to a 14% growth forecast for the industry in Germany. Tillkännagivande • Feb 16
Sleep Cycle AB (publ), Annual General Meeting, May 10, 2022 Sleep Cycle AB (publ), Annual General Meeting, May 10, 2022. Tillkännagivande • Feb 15
Sleep Cycle AB (Publ) Provides Earnings Guidance for the Full Year 2022 Sleep Cycle AB (publ) provided earnings guidance for the full year 2022. In October, Google announced that it was reducing the fee on all Google Play sales from 30% to 15% from 1 January 2022. Sleep Cycle's expected impact on earnings from the reduction is estimated at approximately SEK 2 million for the full year 2022. Tillkännagivande • Jan 26
Sleep Cycle Launches ‘Sleep Goal’ in iOS to Help Users Schedule Better Sleep Sleep Cycle announced the launch of ‘Sleep Goal’ – a new feature in iOS that helps users schedule their wake-up time and bedtime to further improve their sleep routine by setting a weekly sleep goal. Sleep irregularity has been linked to a 10-year risk of cardiovascular disease, greater obesity, hypertension and diabetes. It has also been associated with increased perceived stress and depression. ‘Sleep Goal’ therefore becomes an important tool in helping to curb sleep irregularity as its purpose is to help users plan a consistent sleep routine every week, which will translate into a long-term behavioral change. ‘Sleep Goal’ went through extensive testing before the roll out, which showed high engagement rates for the feature and increased consistency in using the app. The user’s journey is supported by a weekly overview, so they can track their progress. It also serves as an effective reminder to activate the popular smart alarm each night and to remind users that it’s time for bed. Sleep Cycle leads the field in analyzing users’ sleep and presenting this data in easy-to-understand graphs. In line with Sleep Cycle’s mission to continue developing products that help people worldwide improve their sleep, ‘Sleep Goal’ will initially be available for all users on the iOS platform. Tillkännagivande • Dec 03
Sleep Cycle Launches Spatial Audio Content in iOS for Their Sleep Aid Program Sleep Cycle announced the launch of ‘Forest Walk,’ the first installment in a new spatial audio category designed to provide an immersive and relaxing experience for its users. Spatial audio enables listeners to hear three-dimensional audio where sounds appear to be coming from all around you. With the “Forest Walk” sleep aid, Sleep Cycle users will be surrounded by the sounds of nature as they blissfully fall asleep. ‘Forest Walk’ will be available for free within iOS to all users for a limited time only, eventually becoming an exclusive feature for premium users. This new innovative audio series, which also includes ‘Forest Creek’ and ‘Forest Pond,’ will join Sleep Cycle’s existing library of carefully curated and beautifully produced content to help the onset of sleep.